HEALTH CARE RESOURCE UTILIZATION (HCRU) IN HOSPITALIZED FEBRILE NEUTROPENIA (FN) PATIENTS TREATED WITH CHEMOTHERAPY FOR SOLID TUMORS (ST) AND HEMATOLOGICAL MALIGNANCIES (HM) IN BULGARIA

被引：0
|
作者：
Gercheva, L. [1 ]
Goranov, S. [2 ]
Raynov, J. [3 ]
Mihaylova, Z. [4 ]
Mihaylov, G. [5 ]
Karanikolov, S. [6 ]
Petrova, R. [7 ]
机构：
[1] Multiprofile Hosp Act Treatment Sveta Marina EAD, Varna, Bulgaria
[2] Univ Multiprofile Hosp Act Treatment Sveti Georgi, Plovdiv, Bulgaria
[3] Mil Med Acad Multiprofile Hopsital Act Treatment, Sofia, Bulgaria
[4] Mil Med Acad Multiprofile Hosp Act Treatment, Sofia, Bulgaria
[5] Specialized Hosp Act Treatment Hematol Dis EAD, Sofia, Bulgaria
[6] Complex Oncol Ctr Shumen EOOD, Shumen, Bulgaria
[7] Amgen Bulgaria EOOD, Sofia, Bulgaria
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2397
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN238
引用
收藏
页码：A656 / A656
页数：1
相关论文
共 24 条
  • [1] HEALTH CARE RESOURCE UTILIZATION (HCRU) IN HOSPITALIZED FEBRILE NEUTROPENIA (FN) PATIENTS TREATED WITH CHEMOTHERAPY FOR SOLID TUMORS (ST) AND HEMATOLOGICAL MALIGNANCIES (HM) IN BULGARIA (BG), CZECH REPUBLIC (CZ) AND SLOVAKIA (SK) AS OBSERVED IN CLINICAL PRACTICE
    Mihaylov, G.
    Mihaylova, Z.
    Drgona, L.
    Cipkova, A.
    Novak, J.
    Petrova, R.
    VALUE IN HEALTH, 2014, 17 (07) : A657 - A658
  • [2] Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia
    Mihaylov G.
    Mihaylova Z.
    Drgona L.
    Cipkova A.
    Novak J.
    Petrova R.
    memo - Magazine of European Medical Oncology, 2016, 9 (3) : 144 - 152
  • [3] Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US
    Flanigan, Jeanine A.
    Yasuda, Marie
    Chen, Chi-Chang
    Li, Edward C.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (06)
  • [4] Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study
    Ludwig, Heinz
    Bokemeyer, Carsten
    Aapro, Matti
    Boccadoro, Mario
    Gascon, Pere
    Denhaerynck, Kris
    Krendyukov, Andriy
    Abraham, Ivo
    MacDonald, Karen
    FUTURE ONCOLOGY, 2019, 15 (08) : 897 - 908
  • [5] Clinical and microbiological profile of febrile neutropenia in solid tumors and hematological malignancies at a tertiary cancer care center in South India
    Jacob, L. A.
    Lakshmaiah, K. C.
    Govindbabu, K.
    Suresh, T. M.
    Lokanatha, D.
    Sinha, M.
    Vijaykumar, B. R.
    Sumathi, B. G.
    Jayashree, R. S.
    INDIAN JOURNAL OF CANCER, 2014, 51 (04) : 464 - U337
  • [6] HEALTH CARE UTILIZATION (HCU) BY BREAST CANCER (BC) AND NON-HODGKIN LYMPHOMA (NHL) PATIENTS WITH CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA (FN) IN THE NETHERLANDS
    Issa, D. E.
    van Herk-Sukel, M. P. P.
    Gelderblom, H.
    Houweling, L. M. A.
    Jager, A.
    De La Orden, M.
    Lugtenburg, P. J.
    van der Werf-Langenberg, M. E.
    Nortier, J. W. R.
    de Jong, F. A.
    VALUE IN HEALTH, 2012, 15 (07) : A435 - A435
  • [7] The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma
    Zecha, Judith A. E. M.
    Raber-Durlacher, Judith E.
    Laheij, Alexa M. G. A.
    Westermann, Anneke M.
    de Lange, Jan
    Smeele, Ludi E.
    FRONTIERS IN ORAL HEALTH, 2022, 3
  • [8] Predictive factors for antibiotic addition in patients (PTS) with febrile neutropenia (FN) after chemotherapy (CT) for solid tumors and treated with Piperacilin plus Tazobactam (P plus T) monotherapy
    Climent, MA
    Soriano, V
    Gaspar, C
    Muñoz, MA
    Olmos, T
    Burriel, C
    Maiquez, J
    Guillem, V
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S96 - S96
  • [9] Health Care Utilization (HCU) by Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) Patients (pts) with Chemotherapy (CT) Induced Febrile Neutropenia (FN) in the Netherlands
    Gelderblom, Hans
    Lugtenburg, Pieternella J.
    Nortier, Hans W. R.
    Van Herk-Sukel, Myrthe P.
    Issa, Djamila E.
    Jager, Agnes
    De la Orden, Margarita
    Van der Werf-Langenberg, Mirte E.
    Houweling, Leanne M. A.
    De Jong, Floris A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 465 - 466
  • [10] Health care utilization (HCU) by breast cancer (BC) and non-Hodgkin lymphoma (NHL) patients (pts) with chemotherapy (CT) induced febrile neutropenia (FN) in the Netherlands
    Gelderblom, Hans
    Lugtenburg, Pieternella
    Nortier, J. W. R.
    van Herk-Sukel, Myrthe
    Issa, Djamila
    Jager, A.
    De La Orden, Margarita
    van der Werf-Langenberg, Mirte
    Houweling, Leanne
    De Jong, Floris Aart
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
123